LP342, a novel histone deacetylase inhibitor, decreases nitro-oxidative stress, mitochondrial dysfunction and hepatic ischaemia/reperfusion injury in mice.

RPS Pharm Pharmacol Rep · 2023 · PMC10114105 · PMID 37092117

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

near significanceP = 0.054so close (0.05 < p ≤ 0.1)

Treatment with 1.0 mg/kg of LP342 upon reperfusion decreased ALT with near significance by ~43% ( P = 0.054, Figure 2A ).

also in 117 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.